Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 27
Filter
1.
Innate Immun ; 23(3): 319-326, 2017 04.
Article in English | MEDLINE | ID: mdl-28205451

ABSTRACT

Porphyromonas gingivalis produces different LPS isoforms with significant structural variations of their lipid A and O-antigen moieties that can affect its pro-inflammatory and bone-resorbing potential. We show here, for the first time, that P. gingivalis LPS isolated from W83 strain is highly sialylated and possesses significantly reduced inflammatory potential compared with less sialylated ATCC 33277 strain LPS. Nevertheless, the reduction in the endotoxin activity is not mediated by the presence of sialic acid LPS moieties as the sialic acid-free LPS produced by the mutant W83 strain exhibits a similar inflammatory potential to the wild type strain. Furthermore, our findings suggest that the interaction between the sialic acid LPS moieties and the inhibitory CD33 receptor is prevented by endogenously expressed sialic acid on the surface of THP-1 cells that cannot be out-competed by sialic acid containing P. gingivalis LPS. The present study also highlights the importance of endogenous sialic acid as a 'self-associated molecular pattern' and CD33 receptors in modulation of innate immune response as human gingival fibroblasts, which do not express CD33 receptors, and desialylated THP-1 cells have both been found to have much higher spontaneous IL-8 production than naïve THP-1 cells.


Subject(s)
Bacteroidaceae Infections/immunology , Fibroblasts/immunology , Gingiva/pathology , Lipopolysaccharides/immunology , Monocytes/immunology , N-Acetylneuraminic Acid/metabolism , Periodontal Diseases/immunology , Porphyromonas gingivalis/metabolism , Cell Line , Fibroblasts/microbiology , Host-Pathogen Interactions , Humans , Immunity, Innate , Interleukin-8/metabolism , Lipid A/chemistry , Lipopolysaccharides/chemistry , Monocytes/microbiology , Mutation/genetics , N-Acetylneuraminic Acid/chemistry , O Antigens/chemistry , Porphyromonas gingivalis/genetics , Porphyromonas gingivalis/immunology , Protein Processing, Post-Translational , Sialic Acid Binding Ig-like Lectin 3/metabolism
2.
J Investig Clin Dent ; 5(2): 151-3, 2014 May.
Article in English | MEDLINE | ID: mdl-24610586

ABSTRACT

AIM: Recent UK National Institute for Health and Clinical Excellence guidelines state that there is no longer a need for oral antibiotic prophylaxis in patients undergoing dental procedures who are at risk of infective endocarditis (IE), and advocate the importance of maintaining good oral health. As viridans group streptococci (VGS) are common etiological agents of IE and inhabitants of the mouth, the purpose of this study was to examine the efficacy of common high-street mouthwashes against four classes of VGS organisms (salivarius, mitis, anginosus, and mutans groupings). METHODS: The survival of VGS, Streptococcus gordonii (National Collection of Type Cultures [NCTC] 7865), Streptococcus intermedius (NCTC 11324), Streptococcus mutans (NCTC 10449), Streptococcus oralis (NCTC 11427), Streptococcus pneumoniae (NCTC 7465, NCTC 7978, & American Type Culture Collection 49619) and Streptococcus salivarius (NCTC 8618) was assessed in vitro following treatment of approximately 10(7) c.f.u. in planktonic state with four mouthwashes. RESULTS: No organisms were culturable following 1-min exposure, and were not recovered following non-selective enrichment following incubation in Brain Heart Infusion broth supplemented with 0.8% (w/v) yeast extract. CONCLUSIONS: These data indicate that such mouthwashes are able to completely kill VGS organisms tested in planktonic solution, where their use would promote good oral hygiene in patients at risk of IE.


Subject(s)
Anti-Infective Agents, Local/pharmacology , Endocarditis, Bacterial/microbiology , Mouth/microbiology , Mouthwashes/pharmacology , Streptococcal Infections/microbiology , Viridans Streptococci/drug effects , Bacteriological Techniques , Cetylpyridinium/pharmacology , Chlorhexidine/analogs & derivatives , Chlorhexidine/pharmacology , Drug Combinations , Humans , Oral Health , Salicylates/pharmacology , Streptococcus/drug effects , Streptococcus gordonii/drug effects , Streptococcus intermedius/drug effects , Streptococcus mutans/drug effects , Streptococcus oralis/drug effects , Streptococcus pneumoniae/drug effects , Terpenes/pharmacology
3.
J Clin Periodontol ; 40(10): 933-41, 2013 Oct.
Article in English | MEDLINE | ID: mdl-23952216

ABSTRACT

AIM: To determine the levels of LL-37 in and its susceptibility to degradation by components of gingival crevicular fluid (GCF) in periodontal health and disease. MATERIALS AND METHODS: Levels of LL-37 in GCF from periodontitis patients and periodontally healthy subjects were determined by ELISA. In addition, degradation of synthetic/exogenous LL-37 by components of GCF in the presence and absence of inhibitors was determined by matrix-assisted laser desorption/ionization time of flight mass spectrometry. RESULTS: The concentration of native LL-37 in GCF from Porphyromonas gingivalis positive (Pg+) and P. gingivalis negative (Pg-) sites in periodontitis patients was significantly higher than in GCF from healthy subjects. When synthetic LL-37 was added to healthy GCF, the peptide was not degraded. Conversely, GCF from Pg+ sites rapidly degraded synthetic LL-37 which was prevented in the presence of Arg- and Lys- gingipain inhibitors. Synthetic LL-37 was degraded more slowly by GCF from Pg- sites. CONCLUSIONS: LL-37 is detectable in GCF in periodontal health and disease. The rapid degradation of synthetic LL-37 in periodontitis GCF, particularly in Pg+ sites, limits its role as a potential therapeutic in the gingival crevice. These results highlight the need to design stable peptide mimetics of LL-37 as future therapeutics in periodontitis.


Subject(s)
Anti-Bacterial Agents/analysis , Cathelicidins/analysis , Cysteine Proteases/metabolism , Gingival Crevicular Fluid/enzymology , Periodontitis/metabolism , Periodontium/metabolism , Adhesins, Bacterial/analysis , Adhesins, Bacterial/drug effects , Adult , Aged , Antimicrobial Cationic Peptides , Cysteine Endopeptidases/analysis , Cysteine Endopeptidases/drug effects , Cysteine Proteinase Inhibitors/pharmacology , Dental Plaque/microbiology , Enzyme-Linked Immunosorbent Assay , Gingipain Cysteine Endopeptidases , Gingival Crevicular Fluid/microbiology , Humans , Leupeptins/pharmacology , Middle Aged , Peptide Fragments/analysis , Periodontitis/enzymology , Periodontitis/microbiology , Periodontium/enzymology , Porphyromonas gingivalis/enzymology , Porphyromonas gingivalis/isolation & purification , Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization/methods , Tosyllysine Chloromethyl Ketone/pharmacology
4.
Ulster Med J ; 82(3): 164-8, 2013 Sep.
Article in English | MEDLINE | ID: mdl-24505152

ABSTRACT

A study was undertaken to examine the population structure of viridans group streptococci (VGS) isolated the upper respiratory tract of adult and paediatric patients within the community. VGS are common commensal bacterial inhabitants of the upper respiratory tract and valuable sentinel reporters of underlying antibiotic resistance (AR). Laboratory examination of the colonising VGS species may provide a valuable ecological description of the species isolated from the upper respiratory tract and their antibiotic susceptibility, including an estimation of the AR reservoir in this population. Freshly obtained nasal and oropharyngeal swabs from 84 patients were examined by selective conventional culture on Mitis-Salivarius agar and yielded 363 isolates of VGS. Sequence analyses of the rpnB and 16-23S rRNA ITS genes identified these isolates to belong to 10 species of VGS and included S. anginosus, S. australis, S. constellatus, S. infantis, S. mitis, S. oralis, S. parasanguinis, S. salivarius, S. sanguinis and S. vestibularis. The most frequent VGS organisms isolated was S. salivarius (282/363; 78.0%), followed by S. sanguinis (23/363; 6.3%), S. parasanguinis (21/363; 5.8%), S. mitis (18/363; 5.0%), S. anginosus (5/363; 1.4%), S. vestibularis (5/363; 1.4%), S. australis (3/363; 0.8%), S. oralis (3/363; 0.8%), S. infantis (1/363; 0.3%) and S. constellatus (1/363; 0.3%). All patients examined carried at least one VGS organism, where there were 17 combination patterns of carriage of the 10 species of VGS species isolated, where 54.2%, 37.3%, 7.2% and 1.2% of patients harboured one, two, three and four different VGS species, respectively. Antibiotic susceptibility was determined by standard disk diffusion assay testing against four classes of antibiotics, including the b-lactams [cefotaxime, cefuroxime], the tetracyclines [doxycycline], the fluoroquinolones [levofloxacin] and the macrolides [erythromycin]. Overall, there was no resistance to levofloxacin and cefuroxime, with limited resistance to cefotaxime (3.3%) and doxycycline (9.8%). Antibiotic resistance was highest in erythromycin, where 40.9% of isolates were resistant. S. vestibularis was the most antibiotic resistance of all VGS species examined (S. vestibularis v S. salivarius p=0.011), followed by S. anginosis. S. salivarius was the most antibiotic susceptible VGS species examined. Overall, given their infrequency in causing infection, relatively few studies to date have attempted to examine their ecology in their preferred body niche, namely the upper respiratory tract. However, knowing their prevalence is becoming increasingly important in relation to their ability to exclude significant respiratory pathogens, including Streptococcus pneumoniae. In conclusion, these data indicate that VGS colonisation of the upper respiratory tract in individuals within the community is dominated mainly with relatively antibiotic susceptible S. salivarius.


Subject(s)
Anti-Bacterial Agents/pharmacology , Carrier State/microbiology , Respiratory System/microbiology , Viridans Streptococci/classification , Viridans Streptococci/drug effects , Adolescent , Adult , Child , DNA, Bacterial/analysis , Drug Resistance, Bacterial , Humans , Male , Middle Aged , Molecular Typing , Viridans Streptococci/isolation & purification , Young Adult
5.
J Investig Clin Dent ; 3(3): 198-202, 2012 Aug.
Article in English | MEDLINE | ID: mdl-22887906

ABSTRACT

AIM: Previous work has indicated that environmental stresses on bacteria might lead to an upregulation of stress response. LED curing lights (315-400 nm) and other UV lights used in tooth whitening cosmetic procedures might act as stresses. We examined the effect of UV-C light, as a high-energy surrogate to the lower-energy UV-A light used in such instruments, to examine its effect on the antibiotic susceptibility of viridans group streptococci. METHODS: Twelve species of viridans group streptococci were examined in this study: Streptococcus anginosus, Streptococcus australis, Streptococcus cristatus, Streptococcus gordonii, Streptococcus infantis, Streptococcus mitis, Streptococcus mutans, Streptococcus oralis, Streptococcus parasanguinis, Streptococcus pneumoniae, Streptococcus salivarius, and Streptococcus sanguinis. These organisms were exposed to varying degrees of sublethal UV-C radiation, and their minimum inhibitory concentration susceptibility was determined by broth dilution assay against three classes of commonly-used antibiotics: ß-lactams (penicillin), macrolides (erythromycin), and fluoroquinolones (ciprofloxacin). RESULTS: There was no significant difference between antibiotic susceptibility before UV-C exposure and following maximum sublethal stress, prior to cell death due to fatal UV-C exposure. CONCLUSIONS: Exposure to UV-C light will not result in altered antibiotic susceptibility patterns on viridans group streptococci. Given that UV-C is more toxic and mutagenic than UV-A light, it is unlikely than UV-A light would yield any difference in response to such exposure.


Subject(s)
Anti-Bacterial Agents/pharmacology , Ciprofloxacin/pharmacology , Drug Resistance, Bacterial/radiation effects , Erythromycin/pharmacology , Penicillins/pharmacology , Ultraviolet Rays , Viridans Streptococci/drug effects , Microbial Sensitivity Tests , Viridans Streptococci/radiation effects
6.
J Cosmet Sci ; 63(2): 133-7, 2012.
Article in English | MEDLINE | ID: mdl-22591564

ABSTRACT

Skin tanning, either by exposure to natural sunlight or through use of UV sunbeds, has become a popular practice in the US, where it is estimated that approximately 1 million times per day someone in the US uses UV radiation for skin tanning, equating to 30 million Americans (circa 10% of the US population) who use a tanning bed. As well as exposing the host to periods of UV radiation, such practices also expose commensal skin bacteria, including Staphylococcus aureus, to such UV radiation. Previous work has indicated that environmental stresses on bacteria may lead to an upregulation of stress responses, in an attempt for the organism to combat the applied stress and remain viable. UV light may act as an environmental stress on bacteria, and so it was the aim of this study to examine the effect of UVc light on the antibiotic susceptibility of commensal skin bacteria, to determine if UV radiation would increase the antibiotic resistance of such skin flora and thus lead to a potential skin flora with increased antibiotic resistance. Previously, it has been shown that UVc light has a greater mutational effect on bacteria compared to lower-energy UV forms, including UVa and UVb light. Therefore, we decided to employ UVc light in our study to amplify the potential for mutational events occurring in skin staphylococci organisms (n=8) including methicillin-sensitive Staphylococcus aureus (n=2), methicillin-resistant Staphylococcus aureus (n=4), and coagulase-negative staphylococci (Staphylococcus haemolyticus) (n=2) were exposed to varying degrees of sublethal radiation via UVc light, and their minimum inhibitory concentration (MIC) susceptibility was determined by broth dilution assay against three classes of commonly used antibiotics, namely ß-lactams (penicillin), macrolides (erythromycin), and fluoroquinolones (ciprofloxacin). There was no significant difference between antibiotic susceptibility before UVc exposure and until maximum sublethal stress, prior to cell death due to fatal UVc exposure with the cells. These results indicate that UV environmental stress/exposure does not upregulate antibiotic resistance, and therefore these data indicate that UVc radiation does not lead to a more antibiotic-resistant population in the staphylococci organisms post-exposure.


Subject(s)
Anti-Bacterial Agents/pharmacology , Drug Resistance, Bacterial , Staphylococcus/drug effects , Staphylococcus/radiation effects , Ultraviolet Rays , Fluoroquinolones/pharmacology , Macrolides/pharmacology , Staphylococcus/classification , beta-Lactams/pharmacology
7.
Ecotoxicol Environ Saf ; 76(2): 169-74, 2012 Feb.
Article in English | MEDLINE | ID: mdl-22056799

ABSTRACT

Antibiotic resistance in clinical pathogens in humans may be traced back to resistance mechanisms in environmental bacteria and any factors, which are likely to alter (upregulate) resistance in environmental organisms, is of potential and eventual consequence to human pathogens. Furthermore, sublethal doses of gamma radiation to environmental organisms may cause sublethal stress and a selective pressure, which may lead to mutational events that alter the bacterium's susceptibility profile. A gamma (γ) radiation simulation experiment was performed to emulate the exposure of four environmental bacteria, including Listeria innocua, Bacillus subtilis, E. coli and Pseudomonas aeruginosa, to levels of radiation in and around Fukushima, Japan, equating to 1, 10 and 100 years equivalence exposure. Alteration to susceptibility to 14 antibiotics was measured as the primary endpoint. There was no significant alteration in the susceptibility of the Gram-positive organisms, whereas both Gram-negative organisms became slightly more susceptible to the antibiotics tested over time. These data indicate that such radiation exposure will not increase the antibiotic resistance profile of these organisms and hence not add to the global public health burden of increased antibiotic resistance in human bacterial pathogens.


Subject(s)
Anti-Bacterial Agents/pharmacology , Bacteria/drug effects , Drug Resistance, Bacterial/radiation effects , Radioactive Hazard Release , Bacteria/radiation effects , Environment , Escherichia coli/drug effects , Escherichia coli/radiation effects , Humans , Japan , Public Health , Stress, Physiological
9.
J Med Microbiol ; 60(Pt 12): 1782-1786, 2011 Dec.
Article in English | MEDLINE | ID: mdl-21852527

ABSTRACT

The aim of this study was to investigate the reliability of disc diffusion testing with penicillin, erythromycin and ciprofloxacin within the viridans group streptococci (VGS). In total, the antibiotic susceptibilities of 167 VGS isolates were compared by standard disc diffusion and broth microdilution methods, and these phenotypic data were compared to the carriage of the respective gene resistance determinants [ermB and mefA/E (macrolides); QRDR, gyrA, gyrB, parC and parE (quinolones)]. Overall, there were 35 discrepancies [resistant by MIC and susceptible by zone diameter (21.0%)] between MIC and disc diameter when penicillin susceptibility was interpreted by Clinical and Laboratory Standards Institute criteria. Scattergrams showed a bimodal distribution between non-susceptible and susceptible strains when erythromycin susceptibility was tested by both methods. Thirty-four (20.4%) isolates were categorized as resistant by MIC breakpoints, while disc diameter defined these as having intermediate resistance. With ciprofloxacin, three isolates (1.8%) showed minor discrepancies between MIC breakpoints and disc diameter. Isolates non-susceptible to all three antimicrobial agents tested were reliably distinguished from susceptible isolates by disc diffusion testing, except for the detection of low-level resistance to penicillin, where broth microdilution or an alternative quantitative MIC method should be used. Otherwise, we conclude that disc diffusion testing is a reliable method to detect strains of VGS non-susceptible to penicillin, erythromycin and ciprofloxacin, as demonstrated with their concordance to their gene resistance characteristics.


Subject(s)
Anti-Bacterial Agents/pharmacology , Drug Resistance, Bacterial , Microbial Sensitivity Tests/methods , Viridans Streptococci/drug effects , Ciprofloxacin/pharmacology , Drug Resistance, Bacterial/genetics , Erythromycin/pharmacology , Humans , Penicillin Resistance , Penicillins/pharmacology , Reproducibility of Results , Streptococcal Infections/drug therapy , Streptococcal Infections/microbiology , Viridans Streptococci/genetics
10.
J Biol Chem ; 286(34): 29492-500, 2011 Aug 26.
Article in English | MEDLINE | ID: mdl-21705332

ABSTRACT

Induction of endotoxin tolerance leads to a reduced inflammatory response after repeated challenge by LPS and is important for resolution of inflammation and prevention of tissue damage. Enterobacterial LPS is recognized by the TLR4 signaling complex, whereas LPS of some non-enterobacterial organisms is capable of signaling independently of TLR4 utilizing TLR2-mediated signal transduction instead. In this study we report that Porphyromonas gingivalis LPS, a TLR2 agonist, fails to induce a fully endotoxin tolerant state in a human monocytic cell line (THP-1) and mouse bone marrow-derived macrophages. In contrast to significantly decreased production of human IL-8 and TNF-α and, in mice, keratinocyte-derived cytokine (KC), macrophage inflammatory protein-2 (MIP-2), and TNF-α after repeated challenge with Escherichia coli LPS, cells repeatedly exposed to P. gingivalis LPS responded by producing less TNF-α but sustained elevated secretion of IL-8, KC, and MIP-2. Furthermore, in endotoxin-tolerant cells, production of IL-8 is controlled at the signaling level and correlates well with NF-κB activation, whereas TNF-α expression is blocked at the gene transcription level. Interferon ß plays an important role in attenuation of chemokine expression in endotoxin-tolerized cells as shown in interferon regulatory factor-3 knock-out mice. In addition, human gingival fibroblasts, commonly known not to display LPS tolerance, were found to be tolerant to repeated challenge by LPS if pretreated with interferon ß. The data suggest that the inability of the LPS-TLR2 complex to induce full endotoxin tolerance in monocytes/macrophages is related to diminished production of interferon ß and may partly explain the involvement of these LPS isoforms in the pathogenesis of chronic inflammatory diseases.


Subject(s)
Fibroblasts/metabolism , Interferon-beta/biosynthesis , Lipopolysaccharides/pharmacology , Macrophages/metabolism , Toll-Like Receptor 2/metabolism , Animals , Cell Line , Cytokines/biosynthesis , Cytokines/genetics , Drug Resistance/drug effects , Drug Resistance/genetics , Humans , Interferon Regulatory Factor-3/genetics , Interferon Regulatory Factor-3/metabolism , Interferon-beta/genetics , Mice , Mice, Knockout , NF-kappa B/genetics , NF-kappa B/metabolism , Signal Transduction/drug effects , Signal Transduction/genetics , Toll-Like Receptor 2/genetics
11.
J Antimicrob Chemother ; 66(3): 476-86, 2011 Mar.
Article in English | MEDLINE | ID: mdl-21193474

ABSTRACT

OBJECTIVES: Ciprofloxacin is the most frequently used member of the fluoroquinolones during initial eradication therapy of Pseudomonas aeruginosa, as well as during acute pulmonary exacerbations. However, its long-term effect on the susceptibility of the commensal flora within the cystic fibrosis (CF) airways has not yet been examined. The aim of this study was therefore to examine the consequence of oral ciprofloxacin usage on the resistance of the commensal viridans group streptococci (VGS), in terms of MICs and mutational analysis of the quinolone resistance-determining regions (QRDRs). METHODS: The MICs of ciprofloxacin, efflux activities and amino acid substitutions in the QRDRs for 190 isolates of VGS, originating from the sputa of adult CF patients who had been exposed constantly to ciprofloxacin, were examined. VGS organisms included Streptococcus salivarius, Streptococcus mitis, Streptococcus sanguinis, Streptococcus oralis, Streptococcus parasanguinis, Streptococcus infantis, Streptococcus gordonii, Streptococcus anginosus, Streptococcus cristatus, Streptococcus australis and Streptococcus mutans. Ciprofloxacin susceptibility was determined by broth microdilution and QRDRs within the gyrA, gyrB, parC and parE gene loci were explored using sequence analysis. RESULTS: Twenty-seven (14.2%) streptococcal isolates were resistant to ciprofloxacin (MICs ≥8 mg/L) and 21 (11.1%) had reduced susceptibility (MICs 4 mg/L). As a comparator, clinically non-significant and non-invasive VGS organisms were examined in 12 consecutive non-CF patients in the community, where no resistance to ciprofloxacin was observed. Five novel QRDR PCR assays were developed to elucidate mutations within the CF VGS population, where there were six positions, which corresponded to previously reported quinolone resistance responsible mutations, and eight novel potential QRDR resistance mutations. Double mutations in gyrA and parC/parE led to MICs of 16 to >64 mg/L, while single mutations in parC or parE resulted in MICs of 8-32 mg/L and 8 mg/L, respectively. The mean homologies of each species to Streptococcus pneumoniae R6 were: gyrA, 70.3%-95%; gyrB, 69.6%-96.2%; parC, 76.1%-94.8%; and parE, 70.7%-94.7%. The close relatives of S. pneumoniae, S. mitis and S. oralis, showed high similarity for all four genes (more than 86%). CONCLUSIONS: Treatment of P. aeruginosa with oral ciprofloxacin in patients with CF may concurrently reduce antibiotic susceptibility in the commensal VGS flora, where these organisms may potentially act as a reservoir of fluoroquinolone resistance gene determinants for newly acquired and antibiotic-susceptible pathogens, particularly the Streptococcus milleri group.


Subject(s)
Anti-Bacterial Agents/pharmacology , DNA Gyrase/genetics , DNA Topoisomerase IV/genetics , Drug Resistance, Bacterial , Quinolones/pharmacology , Viridans Streptococci/genetics , Adult , Anti-Bacterial Agents/adverse effects , Anti-Bacterial Agents/therapeutic use , Ciprofloxacin/adverse effects , Ciprofloxacin/pharmacology , Ciprofloxacin/therapeutic use , Cystic Fibrosis/complications , DNA, Bacterial/chemistry , DNA, Bacterial/genetics , Drug Utilization , Female , Humans , Male , Microbial Sensitivity Tests , Middle Aged , Quinolones/adverse effects , Quinolones/therapeutic use , Sequence Analysis, DNA , Streptococcal Infections/microbiology , Viridans Streptococci/isolation & purification
12.
J Cyst Fibros ; 10(2): 133-9, 2011 Mar.
Article in English | MEDLINE | ID: mdl-21145793

ABSTRACT

A study was undertaken to examine the population structure of viridans group streptococci (VGS) in the sputum of adult patients with cystic fibrosis (CF). Freshly expectorated sputa (n=58) from 45 adult CF patients were examined by selective conventional culture on Mitis-Salivarius agar and yielded 190 isolates of VGS. Sequence analyses of the rpnB and 16-23S rRNA ITS genes identified these isolates to belong to 12 species of VGS and included S. anginosus, S. australis, S. cristatus, S. gordonii, S. infantis, S. mitis, S. mutans, S. oralis, S. parasanguinis, S. pneumoniae, S. salivarius and S. sanguinis. The most frequently VGS organism isolated was S. salivarius (47/190; 24.7%), followed by S. mitis (36/190; 19%), S. sanguinis (25/190; 13.2%), S. oralis (20/190; 11.0%), S. pneumoniae (19/190; 10.0%), S. parasanguinis (16/190; 8.4%), S. infantis (11/190; 5.8%), S. gordonii (7/190; 3.7%), S. anginosus (4/190; 2.1%), S. cristatus (2/190; 1.1%), S. australis (1/190; 0.5%), S. mutans (1/190; 0.5%) and S. agalactiae (1/190; 0.5%). All, but four, patients harboured at least one VGS species, which ranged from one to five streptococcal species, with a mean of 2.85 species per patient. There was no clonality at the subspecies level employing ERIC RAPD PCR. Antibiotic susceptibility was determined by Minimum Inhibitory Concentration (MIC) testing against penicillin, erythromycin and ciprofloxacin. Overall, resistance to penicillin with all VGS was 73/190 (38.4%) and 167/190 (87.9%) for erythromycin. With regard to ciprofloxacin, 27/190 (14.2%) were fully resistant, whilst a further 21/190 (11.1%) showed intermediate resistance, which equated to approximately three quarters (74.7%) of isolates being fully sensitive to this agent. In addition, as a comparator control population, we examined antibiotic susceptibility, as above, in a non-CF population comprising 12 individuals (50 VGS isolates), who were not receiving chronic antibiotics. In comparison, 8% and 38% of VGS isolates from non-CF individuals were resistant by disk susceptibility testing to penicillin and erythromycin, respectively. None of the non-CF VGS organisms were resistant to ciprofloxacin, but 42% showed intermediate resistance.


Subject(s)
Cystic Fibrosis/microbiology , Streptococcal Infections/microbiology , Streptococcus pneumoniae/genetics , Viridans Streptococci/genetics , Adult , Anti-Bacterial Agents/pharmacology , Drug Resistance, Bacterial/genetics , Humans , Microbial Sensitivity Tests , Sputum/microbiology , Streptococcal Infections/drug therapy , Streptococcus pneumoniae/drug effects , Streptococcus pneumoniae/pathogenicity , Viridans Streptococci/drug effects , Viridans Streptococci/pathogenicity , Virulence
13.
Infect Immun ; 78(10): 4151-6, 2010 Oct.
Article in English | MEDLINE | ID: mdl-20679442

ABSTRACT

Periodontitis, a chronic inflammatory disease of the tissues supporting the teeth, is characterized by an exaggerated host immune and inflammatory response to periopathogenic bacteria. Toll-like receptor activation, cytokine network induction, and accumulation of neutrophils at the site of inflammation are important in the host defense against infection. At the same time, induction of immune tolerance and the clearance of neutrophils from the site of infection are essential in the control of the immune response, resolution of inflammation, and prevention of tissue destruction. Using a human monocytic cell line, we demonstrate that Porphyromonas gingivalis lipopolysaccharide (LPS), which is a major etiological factor in periodontal disease, induces only partial immune tolerance, with continued high production of interleukin-8 (IL-8) but diminished secretion of tumor necrosis factor alpha (TNF-α) after repeated challenge. This cytokine response has functional consequences for other immune cells involved in the response to infection. Primary human neutrophils incubated with P. gingivalis LPS-treated naïve monocyte supernatant displayed a high migration index and increased apoptosis. In contrast, neutrophils treated with P. gingivalis LPS-tolerized monocyte supernatant showed a high migration index but significantly decreased apoptosis. Overall, these findings suggest that induction of an imbalanced immune tolerance in monocytes by P. gingivalis LPS, which favors continued secretion of IL-8 but decreased TNF-α production, may be associated with enhanced migration of neutrophils to the site of infection but also with decreased apoptosis and may play a role in the chronic inflammatory state seen in periodontal disease.


Subject(s)
Apoptosis/physiology , Lipopolysaccharides/immunology , Lipopolysaccharides/pharmacology , Neutrophils/drug effects , Porphyromonas gingivalis/metabolism , Caspase 3/genetics , Caspase 3/metabolism , Cell Line , Cell Movement/drug effects , Cell Movement/physiology , Gene Expression Regulation , Humans , Immune Tolerance , Interleukin-8/genetics , Interleukin-8/metabolism , Lipopolysaccharides/metabolism , Membrane Potential, Mitochondrial/drug effects , Neutrophils/cytology , Neutrophils/physiology , Tumor Necrosis Factor-alpha/genetics , Tumor Necrosis Factor-alpha/metabolism
14.
J Microbiol Methods ; 80(3): 257-61, 2010 Mar.
Article in English | MEDLINE | ID: mdl-20074591

ABSTRACT

A novel microarray was constructed with DNA PCR product probes targeting species specific functional genes of nine clinically significant respiratory pathogens, including the Gram-positive organisms (Streptococcus pneumoniae, Streptococcus pyogenes), the Gram-negative organisms (Chlamydia pneumoniae, Coxiella burnetii Haemophilus spp., Legionella pneumophila, Moraxella catarrhalis, and Pseudomonas aeruginosa), as well as the atypical bacterium, Mycoplasma pneumoniae. In a "proof-of-concept" evaluation of the developed microarray, the microarray was compared with real-time PCR from 14 sputum specimens from COPD patients. All of the samples positive for bacterial species in real-time PCR were also positive for the same bacterial species using the microarray. This study shows that a microarray using PCR probes is a potentially useful method to monitor the populations of bacteria in respiratory specimens and can be tailored to specific clinical needs such as respiratory infections of particular patient populations, including patients with cystic fibrosis and bronchiectasis.


Subject(s)
Gram-Negative Bacteria/isolation & purification , Gram-Negative Bacterial Infections/diagnosis , Gram-Positive Bacterial Infections/diagnosis , Oligonucleotide Array Sequence Analysis/methods , Pulmonary Disease, Chronic Obstructive/microbiology , Respiratory Tract Infections/diagnosis , Streptococcus pneumoniae/isolation & purification , Streptococcus pyogenes/isolation & purification , Chlamydophila pneumoniae/genetics , Chlamydophila pneumoniae/isolation & purification , Coxiella burnetii/genetics , Coxiella burnetii/isolation & purification , DNA, Bacterial/analysis , DNA, Bacterial/genetics , Gram-Negative Bacteria/genetics , Gram-Negative Bacterial Infections/etiology , Gram-Positive Bacterial Infections/etiology , Haemophilus/genetics , Haemophilus/isolation & purification , Humans , Legionella pneumophila/genetics , Legionella pneumophila/isolation & purification , Moraxella catarrhalis/genetics , Moraxella catarrhalis/isolation & purification , Mycoplasma pneumoniae/genetics , Mycoplasma pneumoniae/isolation & purification , Pseudomonas aeruginosa/genetics , Pseudomonas aeruginosa/isolation & purification , Pulmonary Disease, Chronic Obstructive/complications , Respiratory Tract Infections/etiology , Sensitivity and Specificity , Species Specificity , Sputum/microbiology , Streptococcus pneumoniae/genetics , Streptococcus pyogenes/genetics
15.
J Immunol ; 183(12): 7703-9, 2009 Dec 15.
Article in English | MEDLINE | ID: mdl-19933851

ABSTRACT

Although production of cytokines by TLR is essential for viral and bacterial clearance, overproduction can be detrimental, thus controlling these responses is essential. CD33-related sialic acid binding Ig-like lectin receptors (Siglecs) have been implicated in the control of leukocyte responses. In this study, we report that murine Siglec-E is induced by TLRs in a MyD88-specific manner, is tyrosine phosphorylated following LPS stimulation, and negatively regulates TLR responses. Specifically, we demonstrate the Siglec-E expression inhibits TLR-induced NF-kappaB and more importantly, the induction of the antiviral cytokines IFN-beta and RANTES. Siglec-E mediates its inhibitory effects on TIR domain containing adaptor inducing IFN-beta (TRIF)-dependent cytokine production via recruitment of the tyrosine [corrected] phosphatase SHP2 and subsequent inhibition of TBK1 activity as evidenced by enhanced TBK1 phosphorylation in cells following knockdown of Siglec-E expression. Taken together, our results demonstrate a novel role for Siglec-E in controlling the antiviral response to TLRs and thus helping to maintain a healthy cytokine balance following infection.


Subject(s)
Antigens, CD/biosynthesis , Antigens, Differentiation, B-Lymphocyte/biosynthesis , Cytokines/antagonists & inhibitors , Cytokines/biosynthesis , Down-Regulation/immunology , Lipopolysaccharides/pharmacology , Toll-Like Receptors/antagonists & inhibitors , Toll-Like Receptors/physiology , Up-Regulation/immunology , Adaptor Proteins, Vesicular Transport/antagonists & inhibitors , Adaptor Proteins, Vesicular Transport/genetics , Adaptor Proteins, Vesicular Transport/physiology , Animals , Antigens, CD/metabolism , Antigens, CD/physiology , Antigens, Differentiation, B-Lymphocyte/metabolism , Antigens, Differentiation, B-Lymphocyte/physiology , Cell Line , Cell Line, Transformed , Cytokines/genetics , Down-Regulation/genetics , Humans , Mice , Mice, Inbred C57BL , Mice, Knockout , Myeloid Differentiation Factor 88/physiology , NF-kappa B/antagonists & inhibitors , NF-kappa B/metabolism , Phosphorylation/immunology , Protein Tyrosine Phosphatase, Non-Receptor Type 11/metabolism , Protein Tyrosine Phosphatase, Non-Receptor Type 11/physiology , Signal Transduction/genetics , Signal Transduction/immunology
16.
J Antimicrob Chemother ; 64(3): 501-6, 2009 Sep.
Article in English | MEDLINE | ID: mdl-19584106

ABSTRACT

OBJECTIVES: Although long-term use of azithromycin has shown a significant clinical improvement for patients with cystic fibrosis (CF), its long-term effect on the susceptibility of commensal flora within CF airways has not yet been examined. We therefore suggest that long-term use of azithromycin increases macrolide resistance in commensal streptococci. METHODS: Erythromycin susceptibility in naturally colonizing viridans group streptococci (VGS) was characterized, as well as macrolide resistance gene determinants through sequence analysis, in pneumococci (n = 15) and VGS [n = 84; i.e. Streptococcus salivarius (n = 30), Streptococcus mitis (n = 17), Streptococcus sanguinis (n = 11), Streptococcus oralis (n = 10), Streptococcus parasanguinis (n = 6), Streptococcus gordonii (n = 3), Streptococcus infantis (n = 3), Streptococcus cristatus (n = 2), Streptococcus anginosus (n = 1) and Streptococcus australis (n = 1)] isolated from sputum from 24 adult CF patients, who were on oral azithromycin therapy for at least the previous 7 months. RESULTS: Almost three-quarters of isolates (74; 74.7%) were resistant to erythromycin, whilst a further 15 (15.2%) had reduced susceptibility, leaving only 10 (10.1%) isolates susceptible to erythromycin. The majority (89.8%) were not susceptible to erythromycin, as demonstrated by possession of the erm(B) gene in 25/99 (25.3%), the mef(A) gene in 1/99 (1.0%), the mef(E) gene in 75/99 (75.8%) and both erm(B) and mef(E) genes simultaneously in 11/99 (11.1%). These results indicate that genotypic resistance for macrolides is common in VGS in adult CF patients, with efflux being over three times more frequent. CONCLUSIONS: Long-term treatment with azithromycin in CF patients may reduce antibiotic susceptibility in commensal VGS, where these organisms may potentially act as a reservoir of macrolide resistance determinants for newly acquired and antibiotic-susceptible pathogens.


Subject(s)
Anti-Bacterial Agents/pharmacology , Bacterial Proteins/genetics , Drug Resistance, Bacterial , Macrolides/pharmacology , Membrane Proteins/genetics , Methyltransferases/genetics , Streptococcal Infections/microbiology , Streptococcus/genetics , Adult , Anti-Bacterial Agents/therapeutic use , Azithromycin/therapeutic use , Cystic Fibrosis/complications , Cystic Fibrosis/drug therapy , DNA, Bacterial/chemistry , DNA, Bacterial/genetics , Erythromycin/pharmacology , Humans , Microbial Sensitivity Tests , Molecular Sequence Data , Sequence Analysis, DNA , Streptococcus/drug effects , Streptococcus/isolation & purification
17.
J Leukoc Biol ; 85(2): 289-97, 2009 Feb.
Article in English | MEDLINE | ID: mdl-18971287

ABSTRACT

The chemokine eotaxin/CCL11 is an important mediator of leukocyte migration, but its effect on inflammatory cytokine signaling has not been explored. In this study, we find that CCL11 induces suppressor of cytokine signaling (SOCS)1 and SOCS3 expression in murine macrophages, human monocytes, and dendritic cells (DCs). We also discover that CCL11 inhibits GM-CSF-mediated STAT5 activation and IL-4-induced STAT6 activation in a range of hematopoietic cells. This blockade of cytokine signaling by CCL11 results in reduced differentiation and endocytic ability of DCs, implicating CCL11-induced SOCS as mediators of chemotactic inflammatory control. These findings demonstrate cross-talk between chemokine and cytokine responses, suggesting that myeloid cells tracking to the inflammatory site do not differentiate in the presence of this chemokine, revealing another role for SOCS in inflammatory regulation.


Subject(s)
Cell Differentiation/drug effects , Chemokine CCL11/pharmacology , Dendritic Cells/cytology , Granulocyte-Macrophage Colony-Stimulating Factor/pharmacology , Hematopoietic System/cytology , Interleukin-4/pharmacology , Suppressor of Cytokine Signaling Proteins/metabolism , Animals , Cell Line , Cytokines/metabolism , Dendritic Cells/drug effects , Dendritic Cells/metabolism , Endocytosis/drug effects , GTP-Binding Protein alpha Subunits, Gi-Go/metabolism , Hematopoietic System/drug effects , Hematopoietic System/metabolism , Humans , Inflammation Mediators/metabolism , Macrophages/cytology , Macrophages/drug effects , Macrophages/metabolism , Mice , Mice, Inbred C57BL , Receptors, G-Protein-Coupled/metabolism , Signal Transduction/drug effects , Suppressor of Cytokine Signaling 1 Protein , Suppressor of Cytokine Signaling 3 Protein , Suppressor of Cytokine Signaling Proteins/genetics
18.
PLoS One ; 3(4): e1984, 2008 Apr 23.
Article in English | MEDLINE | ID: mdl-18431474

ABSTRACT

BACKGROUND: Chaperones are ubiquitous conserved proteins critical in stabilization of new proteins, repair/removal of defective proteins and immunodominant antigens in innate and adaptive immunity. Periodontal disease is a chronic inflammatory infection associated with infection by Porphyromonas gingivalis that culminates in the destruction of the supporting structures of the teeth. We previously reported studies of serum antibodies reactive with the human chaperone Hsp90 in gingivitis, a reversible form of gingival disease confined to the oral soft tissues. In those studies, antibodies were at their highest levels in subjects with the best oral health. We hypothesized that antibodies to the HSP90 homologue of P. gingivalis (HtpG) might be associated with protection/resistance against destructive periodontitis. METHODOLOGY/PRINCIPAL FINDINGS: ELISA assays using cloned HtpG and peptide antigens confirmed gingivitis subjects colonized with P. gingivalis had higher serum levels of anti-HtpG and, concomitantly, lower levels of attachment loss. Additionally, serum antibody levels to P. gingivalis HtpG protein were higher in healthy subjects compared to patients with either chronic or aggressive periodontitis. We found a negative association between tooth attachment loss and anti-P. gingivalis HtpG (p = 0.043) but not anti-Fusobacterium nucleatum (an oral opportunistic commensal) HtpG levels. Furthermore, response to periodontal therapy was more successful in subjects having higher levels of anti-P. gingivalis HtpG before treatment (p = 0.018). There was no similar relationship to anti-F. nucleatum HtpG levels. Similar results were obtained when these experiments were repeated with a synthetic peptide of a region of P. gingivalis HtpG. CONCLUSIONS/SIGNIFICANCE: OUR RESULTS SUGGEST: 1) anti-P. gingivalis HtpG antibodies are protective and therefore predict health periodontitis-susceptable patients; 2) may augment the host defence to periodontitis and 3) a unique peptide of P. gingivalis HtpG offers significant potential as an effective diagnostic target and vaccine candidate. These results are compatible with a novel immune control mechanism unrelated to direct binding of bacteria.


Subject(s)
Antibodies, Bacterial/immunology , Bacterial Proteins/immunology , HSP90 Heat-Shock Proteins/immunology , Health , Molecular Chaperones/immunology , Periodontitis/immunology , Periodontitis/microbiology , Porphyromonas gingivalis/immunology , Serum , Adult , Amino Acid Sequence , Antibody Formation/immunology , Antigens, Bacterial/chemistry , Antigens, Bacterial/immunology , Bacterial Proteins/chemistry , Cluster Analysis , Colony Count, Microbial , Dental Plaque/microbiology , Disease Susceptibility , Female , Fusobacterium nucleatum/growth & development , Fusobacterium nucleatum/immunology , HSP90 Heat-Shock Proteins/chemistry , Humans , Immunoglobulin G/immunology , Male , Molecular Sequence Data , Peptides/immunology , Porphyromonas gingivalis/growth & development
19.
Am J Infect Control ; 35(9): 619-22, 2007 Nov.
Article in English | MEDLINE | ID: mdl-17980242

ABSTRACT

The aim of this study was to examine the survival dynamics of several epidemic health care-associated (HA) and community-associated (CA) methicillin-resistant Staphylococcus aureus (MRSA) in planktonic state in widely employed denture-cleaning solutions. The bacteriocidal activity of five widely employed denture-cleaning formulations were examined against five phage-types of HA-MRSA (EMRSA 15, EMRSA 16, Irish 1, Irish 2, unique type), as well as a CA-MRSA strain, in this study. Viable MRSA cells (circa 10(5) cfu/mL) were coincubated with optimum recommended working concentrations of denture-cleaning solutions for up to 17 hours (overnight). Recovery experiments were unable to isolate any of the inoculated MRSA organisms 10 minutes post inoculation. The significance and impact of this short study indicates that HA-MRSA and CA-MRSA are not able to remain culturable for 10 minutes in planktonic form, in commonly used denture-cleaning formulations widely available on the UK High Street, suggesting that these formulations may be useful in lowering the numbers of MRSA. Further work is however required to examine the more complex survival dynamics of MRSA in naturally derived denture biofilm, associated with dental plaque and the use of such cleaning formulations.


Subject(s)
Anti-Bacterial Agents/pharmacology , Denture Cleansers/pharmacology , Methicillin Resistance/drug effects , Staphylococcus aureus/drug effects , Community-Acquired Infections/microbiology , Cross Infection/microbiology , Humans , Staphylococcus aureus/classification , Staphylococcus aureus/pathogenicity
20.
J Dent ; 35(9): 712-20, 2007 Sep.
Article in English | MEDLINE | ID: mdl-17689168

ABSTRACT

OBJECTIVES: To review the evidence that the dental unit waterlines are a source of occupational and healthcare acquired infection in the dental surgery. DATA: Transmission of infection from contaminated dental unit waterlines (DUWL) is by aerosol droplet inhalation or rarely imbibing or wound contamination in susceptible individuals. Most of the organisms isolated from DUWL are of low pathogenicity. However, data from a small number of studies described infection or colonisation in susceptible hosts with Legionella spp., Pseudomonas spp. and environmental mycobacteria isolated from DUWL. The reported prevalence of legionellae in DUWL varies widely from 0 to 68%. The risk from prolonged occupational exposure to legionellae has been evaluated. Earlier studies measuring surrogate evidence of exposure to legionellae in dental personnel found a significant increase in legionella antibody levels but in recent multicentre studies undertaken in primary dental care legionellae were isolated at very low rate and the corresponding serological titres were not above background levels. Whereas, a case of fatal Legionellosis in a dental surgeon concluded that the DUWL was the likely source of the infection. The dominant species isolated from dental unit waterlines (DUWL) are Gram-negative bacteria, which are a potent source of cell wall endotoxin. A consequence of indoor endotoxin exposure is the triggering or exacerbation of asthma. Data from a single large practice-based cross-sectional study reported a temporal association between occupational exposure to contaminated DUWL with aerobic counts of >200cfu/mL at 37 degrees C and development of asthma in the sub-group of dentists in whom asthma arose following the commencement of dental training. SOURCES: Medline 1966 to February 2007 was used to identify studies for this paper. STUDY SELECTION: Design criteria included randomised control trials, cohort, and observational studies in English. CONCLUSIONS: Although the number of published cases of infection or respiratory symptoms resulting from exposure to water from contaminated DUWL is limited, there is a medico-legal requirement to comply with potable water standards and to conform to public perceptions on water safety.


Subject(s)
Biofilms , Cross Infection/transmission , Dental Equipment/microbiology , Equipment Contamination , Water Microbiology , Bacteria/classification , Colony Count, Microbial , Disease Susceptibility , Humans , Infection Control, Dental , Occupational Exposure , Risk Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...